Target intelligence / Profile preview

Mitochondrial fatty acid transport machinery (None widely accepted; "mtFAT machinery" is sometimes used in literature, but no universally recognized abbreviation exists[1][2].)

Target
None widely accepted; "mtFAT machinery" is sometimes used in literature, but no universally recognized abbreviation exists[1][2].
Molecular classification
Transporter, Enzyme (components such as carnitine palmitoyltransferases), Other (structural/contact site proteins like ESYT1, VAPB, PLIN5)
01

Overview

The **mitochondrial fatty acid transport machinery** encompasses the molecular systems that mediate the transfer of fatty acids from storage sites (e.g., lipid droplets) into mitochondria for their oxidation and conversion into cellular energy[4][6]. This machinery operates at the interface of lipid droplets, mitochondria, and the endoplasmic reticulum, involving transport proteins (such as CPT1/2), acyl-CoA synthetases, and structural contact site proteins (ESYT1, VAPB, PLIN5, etc.), which collectively regulate fatty acid flux, support energy production, and maintain lipid homeostasis[4][6]. Dysregulation of this machinery is implicated in metabolic diseases, cardiovascular disease, cancer, and other disorders, making it a pharmacologically relevant composite target, though not a single molecule[3][4][6].

Other names
Mitochondrial fatty acid transport complexmtFAT pathwayFatty acid mitochondrial import systemLipid droplet-mitochondria transport system
02

Mechanism of action

Inhibition of fatty acid import (e.g., CPT1 inhibitors block entry of long-chain fatty acids) Modulation of lipid utilization and mitochondrial β-oxidation for energy metabolism

03

Biological functions

Fatty acid import into mitochondriaβ-oxidation of fatty acidsEnergy production (ATP synthesis)Coupling lipid metabolism to mitochondrial energeticsRegulation of lipid droplet–mitochondria contact sites
04

Disease associations

Metabolic syndromeLiver disease (e.g., steatosis)Cardiovascular diseaseCancerType 2 diabetesObesity
05

Safety considerations

Toxicity due to impaired fatty acid oxidation (risk of hepatotoxicity, hypoglycemia, muscle injury)Potential for excessive lipid accumulation, lipotoxicityMitochondrial dysfunction
06

Interacting drugs

Drugs targeting fatty acid oxidation (e.g., etomoxir, which inhibits CPT1)

2 more in the full profile.

07

Biomarkers

Expression levels of mitochondrial fatty acid transporters (e.g., CPT1, CPT2, PLIN5, VAPB)Carnitine/acyl-carnitine ratiosLipid droplet-mitochondria contacts (seen in metabolically active tissues)

Beyond the preview

Go deeper on Mitochondrial fatty acid transport machinery (None widely accepted; "mtFAT machinery" is sometimes used in literature, but no universally recognized abbreviation exists[1][2].).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial fatty acid transport machinery (None widely accepted; "mtFAT machinery" is sometimes used in literature, but no universally recognized abbreviation exists[1][2].).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call